From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA ponders how to regulate next generation sequencing

from Managed Care

In light of the tremendous implications for overuse, misunderstanding, and abuse of a person’s genetic and disease-risk data, regulators have a lot to think about. The FDA is weighing the appropriate regulatory approach to next-generation sequencing, in which a single test potentially can be employed to identify a person’s millions of genetic variants. Results of such tests could be used to diagnose or predict a person’s risk of developing disease and to help physicians and patients to determine appropriate courses of prevention and treatment. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063